50% OFF
MarketBeat All Access
Get 30 days free. Save 50% your first year.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
Claim Your Discount
×
S&P 500   3,664.49 (-0.78%)
DOW   29,308.98 (-0.95%)
QQQ   274.94 (-0.21%)
AAPL   150.32 (-0.07%)
MSFT   237.65 (-0.11%)
META   137.52 (-2.06%)
GOOGL   98.11 (-0.64%)
AMZN   115.29 (+1.33%)
TSLA   277.15 (+0.66%)
NVDA   122.94 (-1.77%)
NIO   17.72 (+0.45%)
BABA   79.11 (+0.39%)
AMD   66.49 (-2.16%)
T   15.61 (-2.50%)
MU   49.16 (-1.88%)
CGC   2.75 (-3.17%)
F   11.98 (-2.68%)
GE   64.82 (+0.42%)
DIS   98.60 (-0.90%)
AMC   7.21 (-9.76%)
PYPL   84.61 (-2.71%)
PFE   43.92 (-0.36%)
NFLX   223.51 (-1.28%)
S&P 500   3,664.49 (-0.78%)
DOW   29,308.98 (-0.95%)
QQQ   274.94 (-0.21%)
AAPL   150.32 (-0.07%)
MSFT   237.65 (-0.11%)
META   137.52 (-2.06%)
GOOGL   98.11 (-0.64%)
AMZN   115.29 (+1.33%)
TSLA   277.15 (+0.66%)
NVDA   122.94 (-1.77%)
NIO   17.72 (+0.45%)
BABA   79.11 (+0.39%)
AMD   66.49 (-2.16%)
T   15.61 (-2.50%)
MU   49.16 (-1.88%)
CGC   2.75 (-3.17%)
F   11.98 (-2.68%)
GE   64.82 (+0.42%)
DIS   98.60 (-0.90%)
AMC   7.21 (-9.76%)
PYPL   84.61 (-2.71%)
PFE   43.92 (-0.36%)
NFLX   223.51 (-1.28%)
S&P 500   3,664.49 (-0.78%)
DOW   29,308.98 (-0.95%)
QQQ   274.94 (-0.21%)
AAPL   150.32 (-0.07%)
MSFT   237.65 (-0.11%)
META   137.52 (-2.06%)
GOOGL   98.11 (-0.64%)
AMZN   115.29 (+1.33%)
TSLA   277.15 (+0.66%)
NVDA   122.94 (-1.77%)
NIO   17.72 (+0.45%)
BABA   79.11 (+0.39%)
AMD   66.49 (-2.16%)
T   15.61 (-2.50%)
MU   49.16 (-1.88%)
CGC   2.75 (-3.17%)
F   11.98 (-2.68%)
GE   64.82 (+0.42%)
DIS   98.60 (-0.90%)
AMC   7.21 (-9.76%)
PYPL   84.61 (-2.71%)
PFE   43.92 (-0.36%)
NFLX   223.51 (-1.28%)
S&P 500   3,664.49 (-0.78%)
DOW   29,308.98 (-0.95%)
QQQ   274.94 (-0.21%)
AAPL   150.32 (-0.07%)
MSFT   237.65 (-0.11%)
META   137.52 (-2.06%)
GOOGL   98.11 (-0.64%)
AMZN   115.29 (+1.33%)
TSLA   277.15 (+0.66%)
NVDA   122.94 (-1.77%)
NIO   17.72 (+0.45%)
BABA   79.11 (+0.39%)
AMD   66.49 (-2.16%)
T   15.61 (-2.50%)
MU   49.16 (-1.88%)
CGC   2.75 (-3.17%)
F   11.98 (-2.68%)
GE   64.82 (+0.42%)
DIS   98.60 (-0.90%)
AMC   7.21 (-9.76%)
PYPL   84.61 (-2.71%)
PFE   43.92 (-0.36%)
NFLX   223.51 (-1.28%)
Followed 146 Times  
NYSE:JNJ

Johnson & Johnson - JNJ Stock Forecast, Price & News

$165.82
-0.90 (-0.54%)
(As of 09/26/2022 01:46 PM ET)
Add
Compare
Today's Range
$164.38
▼
$166.81
50-Day Range
$161.33
▼
$174.59
52-Week Range
$155.72
▼
$186.69
Volume
259,123 shs
Average Volume
7.47 million shs
Market Capitalization
$435.97 billion
P/E Ratio
24.14
Dividend Yield
2.71%
Price Target
$189.78

Johnson & Johnson MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.56 Rating Score
Upside/​Downside
14.4% Upside
$189.78 Price Target
Short Interest
Healthy
0.47% of Float Sold Short
Dividend Strength
Strong
Based on Four Factors
Sustainability
-1.98
Upright™ Environmental Score
News Sentiment
0.23mentions of Johnson & Johnson in the last 14 days
Based on 22 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
-1.78%
From $10.70 to $10.51 Per Share

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.33 out of 5 stars

Medical Sector

265th out of 1,069 stocks

Pharmaceutical Preparations Industry

106th out of 533 stocks

See Top Rated MarketRank™ Stocks Here
JNJ stock logo

About Johnson & Johnson (NYSE:JNJ) Stock

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; TYLENOL acetaminophen products; SUDAFED cold, flu, and allergy products; BENADRYL and ZYRTEC allergy products; MOTRIN IB ibuprofen products; NICORETTE smoking cessation products; and PEPCID acid reflux products. It also offers STAYFREE and CAREFREE sanitary pads; o.b. tampons; adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. It serves general public, retail outlets, and distributors. The company's Pharmaceutical segment offers products for rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; HIV/AIDS and COVID-19 infectious diseases; mood disorders, neurodegenerative disorders, and schizophrenia; prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; thrombosis, diabetes and macular degeneration; and pulmonary arterial hypertension. This segment serves retailers, wholesalers, distributors, hospitals, and healthcare professionals directly for prescription use. Its MedTech segment provides electrophysiology products to treat cardiovascular diseases; neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery under the ACUVUE brand. This segment serves wholesalers, hospitals, and retailers. The company was founded in 1886 and is based in New Brunswick, New Jersey.

Receive JNJ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Johnson & Johnson and its competitors with MarketBeat's FREE daily newsletter.

JNJ Stock News Headlines

September 21, 2022 | marketbeat.com
3 Defensive Stocks With 60-Year Dividend Hike Streaks (JNJ)
With the U.S. economy staring at another recession, it may be a good time to lean on the stability and income of the dividend growth champs.
September 19, 2022 | marketbeat.com
Oracle’s Short-Term Pain Could Be Your Long-Term Gain (JNJ)
Database and cloud solutions provider Oracle (NASDAQ: ORCL) stock got smoked on its fiscal Q1 2023 earnings report. Shares were holding up relatively
September 26, 2022 | Investing Trends (Ad)
Investor Alert: EV Initiatives Create Unsustainable Demand For Lithium
The soaring demand for lithium is driven by worldwide demand for electric vehicles (EVs). Lithium is ideal for electric cars. It's lightweight, stores lots of energy and is rechargeable. Sales of EVs are expected to increase 10-fold by 2030 and estimates are that 1 in 2 cars sold will be electric by 2040.
September 12, 2022 | marketbeat.com
Buy These Stocks for $45,600 Income on $600K
September 2, 2022 | marketbeat.com
Asian stock markets lower ahead of latest US jobs reading
Asian stock markets are lower ahead of U.S. jobs data that might influence Federal Reserve plans for more interest rate hikes to cool surging inflation
September 1, 2022 | marketbeat.com
Stocks end mixed on Wall Street, S&P 500 ekes out a gain
A late burst of buying erased some of the stock market's losses, leaving indexes mixed on Wall Street at the closing bell
August 30, 2022 | marketbeat.com
Shock Absorbers: 3 Low Volatility Dividend Stocks for Bumpy Times
Low volatility dividend plays are built to show their worth over time. These three stocks have historically helped navigate investors through turbulent waters.
September 26, 2022 | finance.yahoo.com
Recession Fears Save Pharma From Drug-Pricing Concerns
September 26, 2022 | Investing Trends (Ad)
Investor Alert: EV Initiatives Create Unsustainable Demand For Lithium
The soaring demand for lithium is driven by worldwide demand for electric vehicles (EVs). Lithium is ideal for electric cars. It's lightweight, stores lots of energy and is rechargeable. Sales of EVs are expected to increase 10-fold by 2030 and estimates are that 1 in 2 cars sold will be electric by 2040.
September 23, 2022 | nasdaq.com
Notable Friday Option Activity: JNJ, INTU, PXD
September 23, 2022 | finance.yahoo.com
10 Best ETFs to Diversify Your Portfolio and Avoid Risks
September 23, 2022 | finance.yahoo.com
10 Dividend Stocks That Raised Their Dividends in 2022
September 23, 2022 | finance.yahoo.com
‘You fight inflation with economic pain’: Billionaire Ray Dalio just issued dire warning to investors — this is what he holds to prepare for the tough times ahead
September 22, 2022 | stocknews.com
3 Stocks That Could Survive a Market Catastrophe
September 22, 2022 | msn.com
Merck, Johnson & Johnson share gains lead Dow's nearly 50-point climb
September 22, 2022 | finance.yahoo.com
Why Johnson & Johnson Stock Defied the Market Downturn Today
September 21, 2022 | seekingalpha.com
Johnson & Johnson: A Defensive Recession Play For A Rocky Economy
September 21, 2022 | msn.com
Johnson & Johnson CEO touts 'smart' data approach to new medicines at new research center
September 20, 2022 | seekingalpha.com
Outlooks Continue To Favor Johnson & Johnson
September 20, 2022 | finance.yahoo.com
UPDATE 2-Uganda declares Ebola outbreak after Sudan strain found
September 19, 2022 | finance.yahoo.com
Cancer victims urge court to end J&J bankruptcy roadblock to lawsuits
September 19, 2022 | msn.com
Merck, Johnson & Johnson share losses lead Dow's nearly 50-point drop
September 19, 2022 | finance.yahoo.com
Defense Wins Ballgames; 3 Blue-Chip Stocks To Consider
September 19, 2022 | finance.yahoo.com
Why Novavax and Johnson & Johnson Stocks Slipped Today
September 19, 2022 | nasdaq.com
VOO, JNJ, LLY, ABBV: Large Inflows Detected at ETF
September 18, 2022 | americanbankingnews.com
Johnson & Johnson to Post Q3 2022 Earnings of $2.57 Per Share, Zacks Research Forecasts (NYSE:JNJ)
September 16, 2022 | finance.yahoo.com
Jurist Noted for Bankruptcy Expertise Will Weigh J&J Talc Appeal
See More Headlines
Receive JNJ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Johnson & Johnson and its competitors with MarketBeat's FREE daily newsletter.

JNJ Company Calendar

Last Earnings
7/19/2022
Ex-Dividend for 9/6 Dividend
8/22/2022
Dividend Payable
9/06/2022
Today
9/26/2022
Next Earnings (Confirmed)
10/18/2022
Fiscal Year End
12/31/2022
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceuticals
Sector
Medical
Current Symbol
NYSE:JNJ
CUSIP
47816010
CIK
200406
Web
www.jnj.com
Phone
(732) 524-0400
Fax
732-214-0332
Employees
141,700
Year Founded
1886

Price Target and Rating

Average Stock Price Forecast
$189.78
High Stock Price Forecast
$205.00
Low Stock Price Forecast
$173.00
Forecasted Upside/Downside
+14.4%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.56
Research Coverage
9 Analysts

Profitability

EPS (Most Recent Fiscal Year)
$6.87
Trailing P/E Ratio
24.14
Forward P/E Ratio
15.50
P/E Growth
2.98
Net Income
$20.88 billion
Net Margins
19.21%
Pretax Margin
21.33%
Return on Equity
36.14%
Return on Assets
14.88%

Debt

Debt-to-Equity Ratio
0.37
Current Ratio
1.42
Quick Ratio
1.17

Sales & Book Value

Annual Sales
$93.78 billion
Price / Sales
4.65
Cash Flow
$12.69 per share
Price / Cash Flow
13.07
Book Value
$28.12 per share
Price / Book
5.90

Miscellaneous

Outstanding Shares
2,629,180,000
Free Float
2,619,978,000
Market Cap
$435.97 billion
Optionable
Optionable
Beta
0.61

Social Links


Key Executives

  • Mr. Alex GorskyMr. Alex Gorsky (Age 62)
    Exec. Chairman
    Comp: $6.18M
  • Mr. Joaquin DuatoMr. Joaquin Duato (Age 59)
    CEO & Director
    Comp: $3.53M
  • Mr. Joseph J. Wolk CPA (Age 55)
    Exec. VP & CFO
    Comp: $2.58M
  • Ms. Jennifer L. Taubert (Age 58)
    Exec. VP & Worldwide Chairman of Pharmaceuticals
    Comp: $2.5M
  • Mr. Robert J. Decker Jr.Mr. Robert J. Decker Jr. (Age 50)
    Controller & Chief Accounting Officer
  • Mr. James Swanson
    Exec. VP & Chief Information Officer
  • Ms. Jessica Moore
    VP of Investor Relations
  • Mr. Michael H. Ullmann (Age 63)
    Exec. VP & Gen. Counsel
  • Mr. Dirk Brinckman
    Chief Compliance Officer
  • Dr. Peter M. Fasolo Ph.D. (Age 59)
    Exec. VP & Chief HR Officer

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions













JNJ Stock - Frequently Asked Questions

Should I buy or sell Johnson & Johnson stock right now?

9 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Johnson & Johnson in the last twelve months. There are currently 4 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" JNJ shares.
View JNJ analyst ratings or view top-rated stocks.

What is Johnson & Johnson's stock price forecast for 2022?

9 equities research analysts have issued 12 month target prices for Johnson & Johnson's shares. Their JNJ share price forecasts range from $173.00 to $205.00. On average, they predict the company's share price to reach $189.78 in the next twelve months. This suggests a possible upside of 13.8% from the stock's current price.
View analysts price targets for JNJ or view top-rated stocks among Wall Street analysts.

How have JNJ shares performed in 2022?

Johnson & Johnson's stock was trading at $171.07 at the beginning of 2022. Since then, JNJ shares have decreased by 2.5% and is now trading at $166.72.
View the best growth stocks for 2022 here.

Are investors shorting Johnson & Johnson?

Johnson & Johnson saw a increase in short interest in the month of August. As of August 31st, there was short interest totaling 12,190,000 shares, an increase of 12.1% from the August 15th total of 10,870,000 shares. Based on an average trading volume of 6,780,000 shares, the days-to-cover ratio is currently 1.8 days. Approximately 0.5% of the company's shares are sold short.
View Johnson & Johnson's Short Interest.

When is Johnson & Johnson's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, October 18th 2022.
View our JNJ earnings forecast.

How can I listen to Johnson & Johnson's earnings call?

Johnson & Johnson will be holding an earnings conference call on Tuesday, October 18th at 8:30 AM Eastern. Interested parties can register for or listen to the call using this link.

How were Johnson & Johnson's earnings last quarter?

Johnson & Johnson (NYSE:JNJ) released its quarterly earnings results on Tuesday, July, 19th. The company reported $2.59 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.57 by $0.02. The company earned $24.02 billion during the quarter, compared to analyst estimates of $23.85 billion. Johnson & Johnson had a trailing twelve-month return on equity of 36.14% and a net margin of 19.21%. The business's revenue was up 3.0% compared to the same quarter last year. During the same period last year, the business posted $2.48 earnings per share.
Read the conference call transcript.

How often does Johnson & Johnson pay dividends? What is the dividend yield for Johnson & Johnson?

Johnson & Johnson announced a quarterly dividend on Monday, July 18th. Shareholders of record on Tuesday, August 23rd will be given a dividend of $1.13 per share on Tuesday, September 6th. This represents a $4.52 dividend on an annualized basis and a yield of 2.71%. The ex-dividend date is Monday, August 22nd.
Read our dividend analysis for JNJ.

Is Johnson & Johnson a good dividend stock?

Johnson & Johnson (NYSE:JNJ) pays an annual dividend of $4.52 per share and currently has a dividend yield of 2.71%. The company has been increasing its dividend for 60 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 65.79%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, JNJ will have a dividend payout ratio of 43.01% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for JNJ.

How will Johnson & Johnson's stock buyback program work?

Johnson & Johnson declared that its Board of Directors has initiated a share buyback program on Wednesday, September 14th 2022, which permits the company to buyback $5,000,000,000.00 in shares, according to EventVestor. This buyback authorization permits the company to repurchase up to 1.2% of its stock through open market purchases. Stock buyback programs are often a sign that the company's leadership believes its stock is undervalued.

What guidance has Johnson & Johnson issued on next quarter's earnings?

Johnson & Johnson updated its FY 2022 earnings guidance on Wednesday, September, 21st. The company provided earnings per share (EPS) guidance of $10.65-$10.75 for the period, compared to the consensus estimate of $10.07. The company issued revenue guidance of -.

What is Alex Gorsky's approval rating as Johnson & Johnson's CEO?

2,535 employees have rated Johnson & Johnson Chief Executive Officer Alex Gorsky on Glassdoor.com. Alex Gorsky has an approval rating of 94% among the company's employees. This puts Alex Gorsky in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Johnson & Johnson own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Johnson & Johnson investors own include AT&T (T), Pfizer (PFE), Verizon Communications (VZ), Walt Disney (DIS), NVIDIA (NVDA), Intel (INTC), JPMorgan Chase & Co. (JPM), Cisco Systems (CSCO), Procter & Gamble (PG) and AbbVie (ABBV).

What is Johnson & Johnson's stock symbol?

Johnson & Johnson trades on the New York Stock Exchange (NYSE) under the ticker symbol "JNJ."

Who are Johnson & Johnson's major shareholders?

Johnson & Johnson's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include State Street Corp (5.37%), Northern Trust Corp (1.29%), Price T Rowe Associates Inc. MD (0.94%), Massachusetts Financial Services Co. MA (0.90%), Legal & General Group Plc (0.72%) and FMR LLC (0.71%). Insiders that own company stock include Ashley Mcevoy, Hubert Joly, Kathryn E Wengel, Michael E Sneed, Robert J Decker, Thibaut Mongon, William D Perez and William Hait.
View institutional ownership trends.

How do I buy shares of Johnson & Johnson?

Shares of JNJ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Johnson & Johnson's stock price today?

One share of JNJ stock can currently be purchased for approximately $166.72.

How much money does Johnson & Johnson make?

Johnson & Johnson (NYSE:JNJ) has a market capitalization of $438.34 billion and generates $93.78 billion in revenue each year. The company earns $20.88 billion in net income (profit) each year or $6.87 on an earnings per share basis.

How many employees does Johnson & Johnson have?

The company employs 141,700 workers across the globe.

Does Johnson & Johnson have any subsidiaries?
The following companies are subsidiares of Johnson & Johnson: 3Dintegrated ApS, ALZA Corporation, AMO (Hangzhou) Co. Ltd., AMO (Shanghai) Medical Devices Trading Co. Ltd Beijing Branch, AMO (Shanghai) Medical Devices Trading Co. Ltd Guangzhou Branch, AMO (Shanghai) Medical Devices Trading Co. Ltd., AMO ASIA LIMITED, AMO Asia Limited (Korea Branch), AMO Asia Limited Taiwan Branch (Hong Kong), AMO Australia Pty Limited, AMO Australia Pty Limited (New Zealand Branch), AMO Canada Company, AMO Denmark ApS, AMO Development LLC, AMO France, AMO Germany GmbH, AMO Groningen B.V., AMO International Holdings Unlimited Company, AMO Ireland, AMO Ireland Ireland Branch, AMO Italy SRL, AMO Japan K.K., AMO Manufacturing USA LLC, AMO Netherlands BV, AMO Nominee Holdings LLC, AMO Norway AS, AMO Puerto Rico Manufacturing Inc., AMO Sales and Service Inc., AMO Singapore Pte. Ltd., AMO Spain Holdings LLC, AMO Switzerland GmbH, AMO U.K. Holdings LLC, AMO United Kingdom Ltd., AMO Uppsala AB, AUB Holdings LLC, Abott Medical Optics, Acclarent Inc., Actelion Ltd, Actelion Pharmaceuticals, Actelion Pharmaceuticals Ltd, Actelion Pharmaceuticals Trading (Shanghai) Co. Ltd., Actelion Pharmaceuticals US Inc., Actelion Treasury Unlimited Company, Akros Medical Inc., Albany Street LLC, Alios BioPharma, Alza Land Management Inc., Anakuria Therapeutics Inc., Animas Diabetes Care LLC, Animas LLC, Animas Technologies LLC, AorTx Inc., Apsis, Aragon Pharmaceuticals, Aragon Pharmaceuticals Inc., Asia Pacific Holdings LLC, Atrionix Inc., Auris Health, Auris Health Inc., Backsvalan 2 Aktiebolag, Backsvalan 6 Handelsbolag, Beijing Dabao Cosmetics Co. Ltd., BeneVir BioPharm Inc., Berna Rhein B.V., BioMedical Enterprises Inc., Biosense Webster (Israel) Ltd., Biosense Webster Inc., Branch of Johnson & Johnson LLC (RU) in Kazakhstan, C Consumer Products Denmark ApS, CSATS Inc., Calibra Medical LLC, Campus-Foyer Apotheke GmbH, Carlo Erba OTC S.r.l., Centocor Biologics LLC, Centocor Research & Development Inc., Cerenovus Inc., ChromaGenics B.V., Ci:Labo Customer Marketing Co. Ltd., Ci:Labo USA Inc., Ci:z Holdings, Ci:z. Labo Co. Ltd., Cilag AG, Cilag GmbH International, Cilag Holding AG, Cilag Holding Treasury Unlimited Company, Cilag-Biotech S.L., CoTherix Inc., Coherex Medical Inc., ColBar LifeScience Ltd., Company Store.com Inc., Conor MedSystems, Cordis International Corporation, Cordis de Mexico S.A. de C.V., Corimmun GmbH, DePuy Hellas SA, DePuy International Limited, DePuy Ireland Unlimited Company, DePuy Mexico S.A. de C.V., DePuy Mitek LLC, DePuy Orthopaedics Inc., DePuy Products Inc., DePuy Spine LLC, DePuy Synthes Gorgan Limited, DePuy Synthes Inc., DePuy Synthes Institute LLC, DePuy Synthes Leto SARL, DePuy Synthes Products Inc., DePuy Synthes Sales Inc., Debs-Vogue Corporation (Proprietary) Limited, Dutch Holding LLC, ECL7 LLC, EES Holdings de Mexico S. de R.L. de C.V., EES S.A. de C.V., EIT Emerging Implant Technologies GmbH, Ethicon Endo-Surgery (Europe) GmbH, Ethicon Endo-Surgery Inc., Ethicon Endo-Surgery LLC, Ethicon Inc., Ethicon LLC, Ethicon PR Holdings Unlimited Company, Ethicon Sarl, Ethicon US LLC, Ethicon Women's Health & Urology Sarl, Ethnor (Proprietary) Limited, Ethnor Farmaceutica S.A., Ethnor del Istmo S.A., FMS Future Medical System SA, Finsbury (Development) Limited, Finsbury (Instruments) Limited, Finsbury Medical Limited, Finsbury Orthopaedics International Limited, Finsbury Orthopaedics Limited, GH Biotech Holdings Limited, GMED Healthcare BV, GMED Healthcare BV (Branch), Global Investment Participation B.V., Guangzhou Bioseal Biotech Co. Ltd., Hansen Medical Deutschland GmbH, Hansen Medical Inc., Hansen Medical International Inc., Hansen Medical UK Limited, Healthcare Services (Shanghai) Ltd., Hickory Merger Sub Inc., I.D. Acquisition Corp., Innomedic Gesellschaft für innovative Medizintechnik und Informatik mbH, Innovative Surgical Solutions LLC, J & J Company West Africa Limited, J&J Pension Trustees Limited, J-C Health Care Ltd., J.C. General Services BV, JJ Surgical Vision Spain S.L., JJC Acquisition Company B.V., JJHC LLC, JJSV Belgium BV, JJSV Manufacturing Malaysia SDN. BHD., JJSV Norden AB, JJSV Produtos Oticos Ltda., JNJ Global Business Services s.r.o., JNJ Holding EMEA B.V., JNJ International Investment LLC, JOM Pharmaceutical Services Inc., Janssen Alzheimer Immunotherapy (Holding) Limited, Janssen BioPharma LLC, Janssen Biologics (Ireland) Limited, Janssen Biologics B.V., Janssen Biotech Inc., Janssen Cilag C.A., Janssen Cilag Farmaceutica S.A., Janssen Cilag S.p.A., Janssen Cilag SPA, Janssen Development Finance Unlimited Company, Janssen Diagnostics LLC, Janssen Egypt LLC, Janssen Farmaceutica Portugal Lda, Janssen Global Services LLC, Janssen Holding GmbH, Janssen Inc., Janssen Irish Finance Unlimited Company, Janssen Korea Ltd., Janssen Oncology Inc., Janssen Ortho LLC, Janssen Pharmaceutica (Proprietary) Limited, Janssen Pharmaceutica NV, Janssen Pharmaceutica S.A., Janssen Pharmaceutical K.K., Janssen Pharmaceutical Sciences Unlimited Company, Janssen Pharmaceutical Unlimited Company, Janssen Pharmaceuticals Inc., Janssen Pharmaceuticals Inc. Japan Branch, Janssen Products LP, Janssen R&D Ireland Unlimited Company, Janssen Research & Development LLC, Janssen Sciences Ireland Unlimited Company, Janssen Scientific Affairs LLC, Janssen Supply Group LLC, Janssen Vaccines & Prevention B.V., Janssen Vaccines Branch of Cilag GmbH International, Janssen Vaccines Corp., Janssen-Cilag, Janssen-Cilag (New Zealand) Limited, Janssen-Cilag A/S, Janssen-Cilag AG, Janssen-Cilag AS, Janssen-Cilag Aktiebolag, Janssen-Cilag B.V., Janssen-Cilag Farmaceutica Lda., Janssen-Cilag Farmaceutica Ltda., Janssen-Cilag GmbH, Janssen-Cilag International NV, Janssen-Cilag Kft., Janssen-Cilag Kft. Branch Office, Janssen-Cilag Limited, Janssen-Cilag Manufacturing LLC, Janssen-Cilag NV, Janssen-Cilag OY, Janssen-Cilag Pharma GmbH, Janssen-Cilag Pharmaceutical S.A.C.I., Janssen-Cilag Polska Sp. z o.o., Janssen-Cilag Pty Ltd, Janssen-Cilag Pty Ltd (Branch), Janssen-Cilag S.A., Janssen-Cilag S.A., Janssen-Cilag S.A. de C.V., Janssen-Cilag de Mexico S. de R.L. de C.V., Janssen-Cilag s.r.o., Janssen-Pharma S.L., Jevco Holding Inc., Johnson & Johnson, Johnson & Johnson (Angola) Limitada, Johnson & Johnson (China) Investment Ltd., Johnson & Johnson (China) Investment Ltd. Beijing Branch, Johnson & Johnson (Egypt) S.A.E., Johnson & Johnson (Hong Kong) Limited, Johnson & Johnson (Ireland) Limited, Johnson & Johnson (Jamaica) Limited, Johnson & Johnson (Kenya) Limited, Johnson & Johnson (Middle East) Inc., Johnson & Johnson (Middle East) Inc. (DHCC Branch), Johnson & Johnson (Middle East) Inc. (JAFZA Branch), Johnson & Johnson (Middle East) Inc. Service Center (DAFZA Branch), Johnson & Johnson (Mozambique) Limitada, Johnson & Johnson (Namibia) (Proprietary) Limited, Johnson & Johnson (New Zealand) Limited, Johnson & Johnson (Philippines) Inc., Johnson & Johnson (Private) Limited, Johnson & Johnson (Thailand) Ltd., Johnson & Johnson (Trinidad) Limited, Johnson & Johnson (Vietnam) Co. Ltd, Johnson & Johnson - Societa' Per Azioni, Johnson & Johnson AB, Johnson & Johnson AB Eesti filiaal (Branch), Johnson & Johnson AG, Johnson & Johnson AG (Zuchwil Branch), Johnson & Johnson Belgium Finance Company BV, Johnson & Johnson Bulgaria EOOD, Johnson & Johnson China Ltd., Johnson & Johnson Consumer (Hong Kong) Limited, Johnson & Johnson Consumer (Thailand) Limited, Johnson & Johnson Consumer B.V., Johnson & Johnson Consumer Health Care Switzerland Branch of Janssen-Cilag AG, Johnson & Johnson Consumer Holdings France, Johnson & Johnson Consumer Inc., Johnson & Johnson Consumer Inc. (Dominican Republic Branch), Johnson & Johnson Consumer NV, Johnson & Johnson Consumer Saudi Arabia Limited, Johnson & Johnson Consumer Services EAME Ltd., Johnson & Johnson Del Paraguay S.A., Johnson & Johnson Dominicana S.A.S., Johnson & Johnson Enterprise Innovation Inc., Johnson & Johnson European Treasury Unlimited Company, Johnson & Johnson Finance Corporation, Johnson & Johnson Finance Limited, Johnson & Johnson Financial Services GmbH, Johnson & Johnson Financial Services GmbH (Branch Office), Johnson & Johnson Gateway LLC, Johnson & Johnson Gesellschaft m.b.H., Johnson & Johnson GmbH, Johnson & Johnson Guatemala S.A., Johnson & Johnson Health Care Systems Inc., Johnson & Johnson Health and Wellness Solutions Inc., Johnson & Johnson Hellas Commercial and Industrial S.A., Johnson & Johnson Hellas Consumer Products Commercial Societe Anonyme, Johnson & Johnson Hemisferica S.A., Johnson & Johnson Holding GmbH, Johnson & Johnson Inc., Johnson & Johnson Industrial Ltda., Johnson & Johnson Innovation - JJDC Inc., Johnson & Johnson Innovation LLC, Johnson & Johnson Innovation Limited, Johnson & Johnson International, Johnson & Johnson International (Belgian Branch) (European Logistics Center), Johnson & Johnson International (Singapore) Pte. Ltd., Johnson & Johnson International (Singapore) Pte. Ltd. (Branch), Johnson & Johnson International Financial Services Unlimited Company, Johnson & Johnson K.K., Johnson & Johnson Kft., Johnson & Johnson Korea Ltd., Johnson & Johnson Korea Selling & Distribution LLC, Johnson & Johnson LLC, Johnson & Johnson Lda, Johnson & Johnson Limited, Johnson & Johnson Limited (Sri Lanka Branch), Johnson & Johnson Luxembourg Finance Company Sarl, Johnson & Johnson Management Limited, Johnson & Johnson Medical (China) Ltd., Johnson & Johnson Medical (Proprietary) Ltd, Johnson & Johnson Medical (Shanghai) Ltd., Johnson & Johnson Medical (Shanghai) Ltd. Beijing Branch, Johnson & Johnson Medical (Suzhou) Ltd., Johnson & Johnson Medical B.V., Johnson & Johnson Medical Devices & Diagnostics Group - Latin America L.L.C., Johnson & Johnson Medical GmbH, Johnson & Johnson Medical Korea Ltd., Johnson & Johnson Medical Limited, Johnson & Johnson Medical Mexico S.A. de C.V., Johnson & Johnson Medical NV, Johnson & Johnson Medical Products GmbH, Johnson & Johnson Medical Pty Ltd, Johnson & Johnson Medical S.A., Johnson & Johnson Medical S.C.S., Johnson & Johnson Medical S.p.A., Johnson & Johnson Medical SAS, Johnson & Johnson Medical Saudi Arabia Limited, Johnson & Johnson Medical Taiwan Ltd., Johnson & Johnson Medikal Sanayi ve Ticaret Limited Sirketi, Johnson & Johnson Medikal Sanayi ve Ticaret Limited Sirketi (Ankara Branch), Johnson & Johnson Medikal Sanayi ve Ticaret Limited Sirketi (Izmir Branch), Johnson & Johnson Middle East - Scientific Office, Johnson & Johnson Middle East FZ - LLC (Lebanese Branch), Johnson & Johnson Middle East FZ-LLC, Johnson & Johnson Middle East FZ-LLC (Ghana Branch), Johnson & Johnson Middle East FZ-LLC (Kenya Branch), Johnson & Johnson Middle East FZ-LLC Branch (TSO) (Saudi Arabia Branch), Johnson & Johnson Morocco Societe Anonyme, Johnson & Johnson NCB (Belgian Branch), Johnson & Johnson Nordic AB, Johnson & Johnson Pacific Pty Limited, Johnson & Johnson Pakistan (Private) Limited, Johnson & Johnson Panama S.A., Johnson & Johnson Personal Care (Chile) S.A., Johnson & Johnson Poland Sp. z o.o., Johnson & Johnson Poland sp. z o.o. oddzial w Warszawie "Consumer", Johnson & Johnson Private Limited, Johnson & Johnson Pte. Ltd., Johnson & Johnson Pte. Ltd. Korea Branch, Johnson & Johnson Pty. Limited, Johnson & Johnson Romania S.R.L., Johnson & Johnson S.A., Johnson & Johnson S.A. de C.V., Johnson & Johnson S.E. Inc., Johnson & Johnson S.E. d.o.o., Johnson & Johnson SDN. BHD., Johnson & Johnson Sante Beaute France, Johnson & Johnson Services Inc., Johnson & Johnson Surgical Vision Inc., Johnson & Johnson Surgical Vision India Private Limited, Johnson & Johnson Taiwan Ltd., Johnson & Johnson UK Treasury Company Limited, Johnson & Johnson Ukraine LLC, Johnson & Johnson Urban Renewal Associates, Johnson & Johnson Vision Care (Shanghai) Ltd., Johnson & Johnson Vision Care Inc., Johnson & Johnson Vision Care Ireland Unlimited Company, Johnson & Johnson d.o.o., Johnson & Johnson de Argentina S.A.C. e. I., Johnson & Johnson de Chile Limitada, Johnson & Johnson de Chile S.A., Johnson & Johnson de Colombia S.A., Johnson & Johnson de Mexico S.A. de C.V., Johnson & Johnson de Uruguay S.A., Johnson & Johnson de Venezuela S.A., Johnson & Johnson del Ecuador S.A., Johnson & Johnson del Peru S.A., Johnson & Johnson do Brasil Industria E Comercio de Produtos Para Saude Ltda., Johnson & Johnson for Export and Import LLC, Johnson & Johnson s.r.o., Johnson Y Johnson de Costa Rica S.A., Johnson and Johnson (Proprietary) Limited, Johnson and Johnson Sihhi Malzeme Sanayi Ve Ticaret Limited Sirketi, LTL Management LLC, La Concha Land Investment Corporation, Latam International Investment Company Unlimited Company, Legal Entity Name, MDS Co. Ltd., McNEIL MMP LLC, McNeil AB, McNeil Consumer Pharmaceuticals Co., McNeil Denmark ApS, McNeil Healthcare (Ireland) Limited, McNeil Healthcare (UK) Limited, McNeil Healthcare LLC, McNeil Iberica S.L.U., McNeil LA LLC, McNeil Nutritionals LLC, McNeil Panama LLC, McNeil Products Limited, McNeil Sweden AB, Medical Device Business Services Inc., Medical Devices & Diagnostics Global Services LLC, Medical Devices International LLC, Medos International Sarl, Medos International Sàrl succursale de Neuchâtel (Branch), Medos Sarl, MegaDyne Medical Products Inc., Menlo Care De Mexico S.A. de C.V., Mentor B.V., Mentor Deutschland GmbH, Mentor Medical Systems B.V., Mentor Partnership Holding Company I LLC, Mentor Texas GP LLC, Mentor Texas L.P., Mentor Worldwide LLC, Micrus Endovascular LLC, Middlesex Assurance Company Limited, Momenta Ireland Limited, Momenta Pharmaceuticals, Momenta Pharmaceuticals Inc., NeoStrata Company Inc., NeoStrata UG (haftungsbeschränkt), Netherlands Holding Company, NeuWave Medical Inc., Neuravi Limited, Novira Therapeutics, Novira Therapeutics LLC, NuVera Medical Inc., OBTECH Medical Sarl, OGX Beauty Limited, OMJ Holding GmbH, OMJ Ireland Unlimited Company, OMJ Pharmaceuticals Inc., Obtech Medical Mexico S.A. de C.V., Omrix Biopharmaceuticals Inc., Omrix Biopharmaceuticals Ltd., Omrix Biopharmaceuticals NV, Ortho Biologics LLC, Ortho Biotech Holding LLC, Ortho-McNeil Pharmaceutical LLC, Orthospin Ltd., Orthotaxy, PT Integrated Healthcare Indonesia, PT. Johnson & Johnson Indonesia, Patriot Pharmaceuticals LLC, Peninsula Pharmaceuticals LLC, Pharmadirect Ltd., Pharmedica Laboratories (Proprietary) Limited, Princeton Laboratories Inc., Productos de Cuidado Personal y de La Salud de Bolivia S.R.L., Proleader S.A., Pulsar Vascular Inc., Regency Urban Renewal Associates, RespiVert Ltd., RoC International, Royalty A&M LLC, Rutan Realty LLC, SYNTHES Medical Immobilien GmbH, Scios LLC, Sedona Singapore International Pte. Ltd., Sedona Thai International Co. Ltd., Serhum S.A. de C.V., Shanghai Elsker For Mother & Baby Co. Ltd, Shanghai Elsker Mother & Baby Co. Ltd Minghang Branch, Shanghai Johnson & Johnson Ltd., Shanghai Johnson & Johnson Pharmaceuticals Ltd., Sightbox LLC, Sodiac ESV, Spectrum Vision Limited Liability Company, Spectrum Vision Limited Liability Partnership, SterilMed, SterilMed Inc., Surgical Process Institute Deutschland GmbH, Synthes Costa Rica S.C.R. Limitada, Synthes GmbH, Synthes Holding AG, Synthes Holding Limited, Synthes Inc., Synthes Medical Surgical Equipment & Instruments Trading LLC, Synthes Produktions GmbH, Synthes Proprietary Limited, Synthes S.M.P. S. de R.L. de C.V., Synthes Tuttlingen GmbH, Synthes USA LLC, Synthes USA Products LLC, TARIS Biomedical, TARIS Biomedical LLC, TearScience Inc., The Anspach Effort LLC, The Vision Care Institute LLC, Tibotec LLC, Torax Medical Inc., UAB "Johnson & Johnson", UAB Johnson & Johnson Eesti Filiaal (Estonian Branch), Vania Expansion, Verb Surgical, Verb Surgical Inc., Vision Care Finance Unlimited Company, Vogue International, Vogue International LLC, Vogue International Trading Inc., WH4110 Development Company L.L.C., XO1, XO1 Limited, Xian Janssen Pharmaceutical Ltd., Xian-Janssen Pharmaceutical Ltd. Beijing Branch Office, Xian-Janssen Pharmaceutical Ltd. Shanghai Branch Office, Zarbee's Inc., and Zarbee's Naturals.
Read More
How can I contact Johnson & Johnson?

Johnson & Johnson's mailing address is ONE JOHNSON & JOHNSON PLZ, NEW BRUNSWICK NJ, 08933. The official website for the company is www.jnj.com. The company can be reached via phone at (732) 524-0400 or via fax at 732-214-0332.

This page (NYSE:JNJ) was last updated on 9/26/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

Twitter Facebook StockTwits Financial Juice YouTube

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.